chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large areas of redness/rash around middle of torso. Bottom of sternum to waist on front and back not on side nor spine or midline on front. Slight itchy ness, warm to touch.   Pretty red, faded a fair amount in 24hrs and only some faint redness 72hrs after appearance
8-12 HOURS AFTER RECEIVING VACCINE. VOMITING X 8.
Laboratory Test Abnormality - Information has been received from a registered nurse concerning a student who in Novermbe 2000.  Was vaccinated with mealses virus vacciene live (+) mumps virus vaccine live (+) rubella vurus baccine live second generation.  subsequently the patients mother who was eights months pregnant experienced a higher than normal rubella titer.  In follow up the nurse reported that she forwarded the forms to the student's mother and that she did not have the information necessary to complete the forms.  additional information is expected.
3-4 cm area around injection site of (R) arm - erythematous & firm.
On 11/22/21, came in for a J&J JANSSEN COVID-19 VACCINE.  Patient answered all 14 questions of the consent form and they were all answered as No.  Patient had no other medical conditions or allergies.  Gave the patient full consultation prior to administration of vaccine and observed patient for a full 15 minutes and no patient had no issues.  The next day patient came in with his wife to accompany her while she was receiving a vaccine as well.  I did ask if he had any reaction from the vaccine, and he stated none whatsoever.  On 12/13/21, patient came in and stated that he had noticed a rash mainly on his back and hand 6 days post injection.  I recommended that he be seen by his doctor to further evaluate the rash. I will document this case in VAERS.
got the shingles shot and got shingles/Suspected Vaccination Failure; around left eye; shingles on my forehead; dry eyes; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got the shingles shot and got shingles/Suspected Vaccination Failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: around left eye) (serious criteria GSK medically significant), shingles (Verbatim: shingles on my forehead) and eye dryness (Verbatim: dry eyes). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster, shingles and eye dryness were not reported.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, shingles and eye dryness to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, ophthalmic herpes zoster, shingles and eye dryness to be related to Shingles vaccine.   Additional Information: GSK receipt date: 26-MAR-2023 The case was received from the patient interactive digital media. The patient got the shingles shot and about a year later he/she got the shingles on his/her forehead and around left eye. The patient stated that it was very uncomfortable and had very dry eyes that made it worse on him/her. The patient stated that he/she was so glad that he/she had gotten the shot and it was no fun. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Severe pain at injection site, redness about 4" to 5" in diameter, severe headache. Exacerbation of both COPD and Familial tremors symptoms. Difficulty breathing, runny nose, headache, exaggerated tremors of the hands and mouth.
Generalized headache; Fatigue; Body Aches; Chills; Warm at the injection site; Red rash; Red rash; Arm was sore the day of injection; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE WARMTH (Warm at the injection site), INJECTION SITE PAIN (Arm was sore the day of injection), INJECTION SITE ERYTHEMA (Red rash), INJECTION SITE RASH (Red rash) and HEADACHE (Generalized headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced INJECTION SITE PAIN (Arm was sore the day of injection). On 06-Jan-2021, the patient experienced INJECTION SITE WARMTH (Warm at the injection site), INJECTION SITE ERYTHEMA (Red rash) and INJECTION SITE RASH (Red rash). On 09-Jan-2021, the patient experienced HEADACHE (Generalized headache), FATIGUE (Fatigue), MYALGIA (Body Aches) and CHILLS (Chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (Warm at the injection site), INJECTION SITE PAIN (Arm was sore the day of injection), HEADACHE (Generalized headache), FATIGUE (Fatigue), MYALGIA (Body Aches) and CHILLS (Chills) outcome was unknown and INJECTION SITE ERYTHEMA (Red rash) and INJECTION SITE RASH (Red rash) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt had temp. 102 F X approx. 24 hrs post DTP#1/TOPV#1 vaccine- also had swelling at site of shot- "high pitched crying & very irritable X 48 hrs post DPT #1
Stomach aches, hair falling out in isolated spots (alopecia) on head and eyebrows, headaches, inability to sleep, depression.
10 minutes after receiving a vaccine patient notified pharmacist of possible reaction. Patient stated that she has had tingling in the lips and a little bit of throat swelling, but denied any difficulty breathing. Patient was given 1 dose of benadryl (25mg) and water. Patient remained in the pharmacy for 45 minutes for observation. Symptoms subsided after benadryl.
Papulo-vesicular rash on trunk, extremities and scalp (15-20 lesions).
test positive for COVID-19; test positive for COVID-19; This is a spontaneous report from a contactable consumer (patient). A 26-year-old female patient received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Dec2020 at single dose in left arm for covid-19 immunization. There was none medical history or concomitant medications. The reporter reported that she got the vaccine on the 20Dec2020 and found out Monday (21Dec2020) that she was exposed to someone who was positive so they used a rapid test post exposure on the 22Dec2020 that the result was positive for COVID-19. She reported she knew that the vaccine would not have given her COVID, and it was likely she had it before she got the vaccine and didn't know she had it because she didn't have symptoms. The outcome was unknown.  Information about lot/batch number has been requested.
The vaccine was given 06/21/2006, a phone call was received on 06/23/2006 from mom, stating the patient's left arm was red, swollen, afebrile with no drainage or red streaks. Mom was given the option of an appointment which she declined. Mom talked to the doctor on call Saturday, 06/24/2006 PM, and was advised to go to Urgent Care. The patient was diagnosed with cellulitis of the left arm and given Keflex. On 06/26/2006, a phone call was received from mom stating the left arm has has a "knot" although much better.
Headache,  chills, nauseous, dry heaves, no treatment, eventually passed
DT given outside of recommended age. Pt should have received Td. Per Sanofi Pasteur no need to revaccinate with Td.
Brain Fog that has persisted as dizziness, Imbalance and Gait Disorder
"Covid arm" large 2-3" red spot at injection site, itchy, tender, felt hard to the touch
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Shellfish" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 30Mar2023, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: Body temperature: (unspecified date) 99 degree; SARS-CoV-2 test: (28Mar2023) Negative; (30Mar2023) Positive; (01Apr2023) Positive, notes: Today is April 1, and I  am still positive (very dark line). Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Pt. c/o nausea and dizziness.  Pt. seen and assessed by EMT and VS are: BP 104/71, HR 60, O2 100%.  Pt. voiced that she had not eaten prior to vaccine but started to feel better in 15 minutes into observations. Pt. cleared to go by EMT.
About after 5 minutes after received the Covid vaccine, patient passed out and had seizure. She became conscious after about a minute. She doesn't respond when we tried to talk to her. She became unconscious/conscious couple times before the ambulance came. Ambulance employees said all her vitals signs is normal. But she seems like  she does not aware of her surrounding. Ambulance took her to hospital.
2 days after getting vaccine, arm became swollen, red, very tender, had difficulty raising arm. Had sweats today. Had some mild itching until he took some benadryl on 8/24/09.
Right deltoid 75mm x 86mm red, swollen, hot to touch, Benadryl and Tylenol.
Received flu shot from my workplace on Wednesday 9/8. The next week Monday 9/13 I started feeling soreness in my neck and around my left ear. Small areas that I thought were insect bites were around my ear. Symptoms persisted so I went to an Urgent Care clinic on Thursday 9/16 and was diagnosed with Shingles.
Pt received Flu vaccine & 5 minutes afterwards c/o belly hurting, nauseated, & color change as color turned very pale, skin clammy. HR - 116/min. Pulse O2 99%. RR 24/min. Pt crying & upset prior to vaccine & upset after vaccine given.
I started out with a small red, hot  to the touch spot - it had  bumps - a slight itch and no pain on left arm below the actual site where the injection site was. And on January 20th. It proceeded to get larger and on January 22nd I had a video call with Dr to have her look. It was still growing. 1/25/2021 - it was still getting larger - it ended up being about at least 6 inches long and 4 to five inches wide at the largest time. After that it started to decrease and it went away. And by the next week it was gone.
Hot heated feeling from her ears to her wrist; Pain that also radiates from her ears to her wrist; Stiff neck to the right side; Cannot lift her right arm up to her chest; Nausea; A spontaneous report was received from a non-healthcare professional concerning a 25 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced hot heated feeling from her ears to her wrist, pain that also radiates from her ears to her wrist, stiff neck to the right side, nausea, cannot lift her right arm up to her chest.  No medical history was reported.  No concomitant medication was reported.  On 12-Jan-2021, prior to the onset of the events hot heated feeling from her ears to her wrist, pain that also radiates from her ears to her wrist, stiff neck to the right side, nausea, cannot lift her right arm up to her chest, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012L20A) via an intramuscular route in right arm for prophylaxis of COVID-19 infection.  On 12-Jan-2021, the patient experienced hot heated feeling from her ears to her wrist, pain that also radiates from her ears to her wrist, stiff neck to the right side, nausea, cannot lift her right arm up to her chest.  Laboratory details was not provided.  Treatment medication included Benadryl at an unknown dose and frequency via an unknown route.  Action taken with mRNA-1273 in response to the events hot heated feeling from her ears to her wrist, pain that also radiates from her ears to her wrist, stiff neck to the right side, nausea, cannot lift her right arm up to her chest was not provided.  The outcome of the events hot heated feeling from her ears to her wrist, pain that also radiates from her ears to her wrist, stiff neck to the right side, nausea, cannot lift her right arm up to her chest was not provided.  The reporter did not provide the assessment of the events hot heated feeling from her ears to her wrist, pain that also radiates from her ears to her wrist, stiff neck to the right side, nausea, cannot lift her right arm up to her chest to study drug.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Maximilien has been experiencing nose bleeds.  It is happening almost daily and the amount of blood lost is significant. He has also been feeling sick and this started a week and half after the shoot He does not have a history of nose bleeds and nor does anyone the family
left side of his face and jaw swollen; does not feel really well; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (left side of his face and jaw swollen), MALAISE (does not feel really well) and PAIN IN EXTREMITY (arm sore) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE and BENAZEPRIL.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced SWELLING FACE (left side of his face and jaw swollen), MALAISE (does not feel really well) and PAIN IN EXTREMITY (arm sore). On 31-Jan-2021, PAIN IN EXTREMITY (arm sore) had resolved. At the time of the report, SWELLING FACE (left side of his face and jaw swollen) and MALAISE (does not feel really well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included diphenhydramine (Benadryl).
Reporter states pt was vaxed w/7 times nl dose of Hep B vax 25JUL91 & on 26JUL91 pt devel swelling of hands, itching palms, nausea, upset stomach, general malaise & a pruritic rash on the back of knees & inside elbow;
Patient felt faint within 2 minutes of vaccination. His vision went dark. When I walked back into the room he was pale and sweating, but responding to questions from the person he arrived with. His arm twitched a few times and his head rolled to the side for a few seconds. Then he regained consciousness, but momentarily looked confused. The patient has a history of seizures, but has not suffered from one in 10 years. After that, the patient remained alert, but continued to sweat and felt light headed for most of standard wait time post vaccination. After the 15 minute wait period the patient felt more normal and left.
Headache, body aches, fever, chills, light-headed, nauseous, heart rate went from  92-176 in a few minutes.
Allergic reaction/Reaction or allergies; Stuffy head; nose began to run and began to sneeze; sneeze; Nasal stuffiness; Seasonal allergies; Rheumatoid arthritis; Joint and muscle pain that are worse; Joint and muscle pain that are worse; This is a spontaneous report from a non-contactable consumer (patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was not reported), via an unspecified route of administration on 29Mar2021 as single dose for COVID-19 immunization; and treprostinil sodium (TYVASO), via resp inhalation from Feb2021 to an unspecified date, at 18-54mug (3-9 breaths), 4x/day for secondary pulmonary arterial hypertension. Medical history included ongoing secondary pulmonary arterial hypertension, ongoing arthralgia, ongoing myalgia, seasonal allergy, and hypertension from an unknown date. Concomitant medications included sildenafil citrate taken for an unspecified indication; and amlodipine besilate taken for hypertension. The patient previously took meloxicam for joint pain. On an unspecified date in 2021, the patient experienced joint and muscle pain that are worse, rheumatoid arthritis and seasonal allergies. The patient had joint and muscle pain for a while, but was worse since starting treprostinil sodium. The event of rheumatoid arthritis was considered as medically significant. The patient had joint and muscle issues (arthralgia, myalgia, and rheumatoid arthritis) that could be debilitating, reported that they were getting better with the Nabumetone. On 29Mar2021, the patient had nasal stuffiness that started when she went on an outing. She felt like she was doing better this week than last week (at time of report). On 31Mar2021, the patient reported that she was having a reaction or allergies. She received her first COVID vaccine on 29Mar2021 and felt fine but woke up on Tuesday (30Mar2021) with stuffy head, nose began to run, and began to sneeze. The action taken in response to the events for treprostinil sodium was unknown. The outcome of the events arthralgia and myalgia was recovering, for rheumatoid arthritis was not recovered, and for other events was unknown.  The reporter's causality for the event of myalgia and arthralgia with IH Tyvaso was considered to be possibly related. The reporter did not provide causality for the events of rheumatoid arthritis and seasonal allergy.  Case Comment/Senders Comment: The company has assessed the serious adverse event of drug hypersensitivity and rheumatoid arthritis as not related to IH treprostinil and TD-300/A device. Drug hypersensitivity was likely due to administration of COVID vaccine. Rheumatoid arthritis was likely an underlying medical condition in this 66-year-old patient based on an implausible time to onset for the reported event.  Information on the lot/batch number has been requested.
Varicella - Information has been received from a physician concerning a 6 year old patient who on 30 July 1998 was vaccianted with varicella virus vaccine live.  At  the end of April of 2000, the patient developed chickenpox.  It was indicated that this seemed to be a mild case of chickenpox, but the office only saw the patient in the beginning of the breakout.  An additonal patient (waes 00051071) had a similar experience following exposure to varicella virus vaccine live.  Additional information has been requested.
Soon after the first dose patient developed lymphadenopathy beneath the L armpit (location of vaccine administered). This resolved. After the second dose developed lymphadenopathy beneath the R armpit (location of vaccine administered on R arm). X 4 days ago developed new onset Shingles in V1 distribution L face. Patient has been started on anti viral treatment.  COVID Vaccine Dose 1: 2/9/2021 L arm COVID Vaccine Dose 2: 3/2/2021 R arm; small lump under armpit, small, resolved Shingles rash: 3/15/2021
On or about March 16, 2021, my left ankle swollen and hot to touch; sought and received medical treatment on March 25, 2021, and after a dobbler and ct scan was diagnosed with bilateral pulmonary emboli. Treated at  Emergency Department and placed on Eliquis 5mg x 2 @ day for 7 days and then for 23 day - 1tab x 2 a day.
Nausea started after waking from nap, very tired, Nausea continued then Vomiting started later around 10:00 PM - continued for an hour off and on, hydration with H2O, then as tolerated with Gatorade.
Headache, Myalgia, Fever, SkinRash, NauseaVomiting, Above symptoms have persisted for 7 days post-vaccination Narrative:  Prolonged post-vaccine reaction as described (following both doses of Moderna Covid vaccination, worse after second dose 1/21/21.)
encephalitis; This case was reported by a physician and described the occurrence of encephalitis in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, immediately after receiving Shingrix, the patient experienced encephalitis (serious criteria GSK medically significant). On an unknown date, the outcome of the encephalitis was unknown.   It was unknown if the reporter considered the encephalitis to be related to Shingrix.  Additional details were received as follows: This case was reported during chronic obstructive pulmonary disease (COPD) speaker training by the attending trainees. The age at vaccination was not reported. The age group was not provided but was selected adult as per the vaccine indication. The reporter's friend presented with encephalitis shortly after vaccination with Shingrix. The reporter gave permission to follow up.
Patient experienced jaw pain with high blood pressure (200/72) within 15 minutes of receiving vaccine administration. History of aortic dissection.
Myocarditis Following mRNA COVID-19 Vaccine; This is a literature report for the following literature source(s):  A patient (no qualifiers provided) received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant), outcome "unknown", described as "Myocarditis Following mRNA COVID-19 Vaccine". Sender's Comments: As there is limited information in the case provided, the causal association between the reported event: "Myocarditis" and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.   The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.